Related Experiment Video
Updated: Jan 24, 2026
07:10
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
22.6K
Hepatic involvement in sarcoidosis
V V Fomin1, M Yu Brovko2, M V Kalashnikov3
1I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Faculty of Medicine, Department of Internal Medicine No.1, Moscow, Russia.
Terapevticheskii Arkhiv
|May 17, 2019
Summary
Sarcoidosis frequently affects the liver, presenting diverse symptoms from asymptomatic cases to cirrhosis. Liver biopsy is crucial for diagnosing hepatic sarcoidosis and ruling out other granulomatous liver diseases.
Area of Science:
- Immunology
- Hepatology
- Pathology
Background:
- Sarcoidosis is a multisystem granulomatous disease with unknown causes.
- Liver involvement is common in sarcoidosis, ranging from mild lesions to severe cirrhosis.
- Clinical presentation varies widely, impacting liver function tests and potentially causing portal hypertension.
Discussion:
- Liver biopsy is essential for diagnosing hepatic sarcoidosis.
- Histopathological examination must differentiate sarcoidosis from other granulomatous liver conditions, particularly primary biliary cholangitis.
- Current therapeutic strategies for hepatic sarcoidosis lack standardization.
Key Insights:
- Hepatic sarcoidosis diagnosis relies heavily on liver biopsy.
- Differential diagnosis is critical to exclude conditions like primary biliary cholangitis.
- There is an unmet need for established treatment guidelines.
Outlook:
- Further research is needed to elucidate the etiology of sarcoidosis.
- Development of standardized diagnostic criteria and treatment protocols for hepatic sarcoidosis is warranted.
- Investigating novel therapeutic targets could improve patient outcomes.
Related Concept Videos
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
265
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
265
01:21Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
01:26Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
220
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
220
01:16Hepatic Drug Excretion: Influencing Factors
543
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
543
01:14Hepatic Drug Clearance: Role of Transporters
305
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
305